Description

The Johns Hopkins Department of Radiology and Radiological Science is seeking an experienced physician-scientist to lead our Division of Nuclear Medicine and Molecular Imaging. The Division combines the highest standards of clinical imaging with cutting-edge research, while educating and guiding the next generation of Nuclear Medicine and Molecular Imaging professionals. State-of-the-art equipment and a broad base of experience support clinical and research programs involving PET/CT, SPECT/CT and theranostics. 

The Division Chief will lead a large multi-disciplinary team and would be expected to have achieved distinction in clinical imaging, research and teaching. The Division Chief has responsibility for all aspects of the clinical program and will be a board-certified physician (ABR or ABNM), reporting directly to the Chair of Radiology.

Johns Hopkins is nationally and internationally recognized for its leadership in theranostics and molecular imaging and is formally designated as an SNMMI Comprehensive Radiopharmaceutical Therapy Center of Excellence.

Research infrastructure within the division is well-developed with extensive radiochemistry facilities, dedicated research PET/CT instrumentation, lab space, image analysis facilities, and associated expertise. The Division partners with NIH, industry and other academic collaborators worldwide to pursue research over a range of applications including the creation of novel radiopharmaceuticals that foster the development of new medical imaging techniques and disease treatments.

The Division also trains future nuclear medicine leaders through the Nuclear Medicine Residency Program and the Molecular Imaging (DR/NM) Residency Program. The Division also offers a one-year fellowship program for specialized training in both clinical and research aspects of PET/CT.

Highlights:

        Unique tripartite leadership opportunity at a preeminent academic medical institution.

        Johns Hopkins is home to groundbreaking nuclear medicine discoveries including neuroreceptor PET, PSMA-targeted PET agents and quantitative assessment of tumor response to treatment using PET.  

        State-of-the-art PET Center supporting clinical and research imaging using multiple PET/CTs, including one dedicated for research use.  

        In-house cyclotron, radiochemistry lab and associated expertise.  

        Ongoing expansion of PET/CT clinical services at the main campus as well as outpatient centers.

        A rapidly expanding theranostics clinical program, delivering FDA-approved radioligand therapies and serving as a regional and national referral center for complex oncologic care.

        Strategic expansion of therapeutic agents and clinical indications, positioning the Division at the forefront of personalized radiopharmaceutical therapy.

        Active leadership in investigator-initiated and industry-sponsored clinical trials of next-generation theranostic agents, spanning early-phase translation through late-stage clinical evaluation.

        Deep multidisciplinary integration with oncology, urology, endocrinology, medical physics, and radiopharmacy, enabling coordinated, patient-centered precision care.

        A top nuclear medicine residency program, as ranked by Doximity and US News and World Report.

        Potential for Henry N. Wagner Jr., MD., Endowed Professorship in Nuclear Medicine, pending candidate qualifications and Chair discretion. 

Candidates should submit their CV to Dr. Jenny Hoang, Interim Chair of the Department of Radiology, at jenny.hoang@jhu.edu